Expression of mdr1 is required for efficient long term regeneration of dystrophic muscle

Experimental Cell Research

Volumn 313, Issue 11, 2007, Pages 2438-2450

  Israeli, David ^a   Ziaei, Simindokht ^a   Gjata, Bernard ^a   Benchaouir, Rachid ^a   Rameau, Philippe ^a   Marais, Thibaut ^a   Fukada, So ichiro ^b   Segawa, Masashi ^b   Yamamoto, Hiroshi ^b   Gonin, Patrick ^a   Danos, Olivier ^a   Garcia, Luis ^a  

^a GÉNÉTHON   (France)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

MDR1; mdx; Muscle; Regeneration; Stem cells

Indexed keywords

DYSTROPHIN; GENE PRODUCT; MULTIDRUG RESISTANCE PROTEIN 1; PROTEIN MDR1A; PROTEIN MDR1B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; KNOCKOUT MOUSE; MALE; MDR1A GENE; MDR1B GENE; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE POTENTIAL; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TISSUE REGENERATION;

MUS;

EID: 34249977084     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2007.02.036     Document Type: Article

References (55)

1. Charge S.B., and Rudnicki M.A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84 (2004) 209-238
2. Collins C.A., Olsen I., Zammit P.S., Heslop L., Petrie A., Partridge T.A., and Morgan J.E. Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122 (2005) 289-301
3. Shi X., and Garry D.J. Muscle stem cells in development, regeneration, and disease. Genes Dev. 20 (2006) 1692-1708
4. Hoffman E.P. Dystrophinopathies. 7th ed. (2001), Cambridge Univ. Press
5. McGeachie J.K., Grounds M.D., Partridge T.A., Morgan J.E., Pagel C.N., and Sherratt T. Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J. Neurol. Sci. 119 (1993) 169-179
6. Pagel C.N., and Partridge T.A. Covert persistence of mdx mouse myopathy is revealed by acute and chronic effects of irradiation. J. Neurol. Sci. 164 (1999) 103-116
7. Pastoret C., and Sebille A. Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse. Muscle Nerve 18 (1995) 1147-1154
8. Israeli D., Benchaouir R., Ziaei S., Rameau P., Gruszczynski C., Peltekian E., Danos O., and Garcia L. FGF6 mediated expansion of a resident subset of cells with SP phenotype in the C2C12 myogenic line. J. Cell Physiol. 201 (2004) 409-419
9. Gottesman M.M., Fojo T., and Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev., Cancer 2 (2002) 48-58
10. Schinkel A.H., Mayer U., Wagenaar E., Mol C.A., van Deemter L., Smit J.J., van der Valk M.A., Voordouw A.C., Spits H., van Tellingen O., Zijlmans J.M., Fibbe W.E., and Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4028-4033
11. Beltrami A.P., Barlucchi L., Torella D., Baker M., Limana F., Chimenti S., Kasahara H., Rota M., Musso E., Urbanek K., Leri A., Kajstura J., Nadal-Ginard B., and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114 (2003) 763-776
12. Chaudhary P.M., and Roninson I.B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66 (1991) 85-94
13. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., and Melton D.A. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298 (2002) 597-600
14. Terskikh A.V., Miyamoto T., Chang C., Diatchenko L., and Weissman I.L. Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102 (2003) 94-101
15. Wagner W., Ansorge A., Wirkner U., Eckstein V., Schwager C., Blake J., Miesala K., Selig J., Saffrich R., Ansorge W., Ho A.D., Kohler T., Leiblein S., Borchert S., Eller J., Rost A.K., Lassner D., Krahl R., Helbig W., Wagner O., and Remke H. Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis absolute levels of MDR-1, MRP, and BCL-2 MRNA and tumor remission in acute leukemia. Blood 104 (2004) 675-686
16. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A., van der Valk M.A., Robanus-Maandag E.C., te Riele H.P., Berns A.J.M., and Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77 (1994) 491-502
17. Croop J.M., Raymond M., Haber D., Devault A., Arceci R.J., Gros P., and Housman D.E. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol. 9 (1989) 1346-1350
18. Scotto K.W. Transcriptional regulation of ABC drug transporters. Oncogene 22 (2003) 7496-7511
19. Johnstone R.W., Ruefli A.A., Tainton K.M., and Smyth M.J. A role for P-glycoprotein in regulating cell death. Leuk. Lymphoma 38 (2000) 1-11
20. Pallis M., Turzanski J., Higashi Y., and Russell N. P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype. Leuk. Lymphoma 43 (2002) 1221-1228
21. Spencer M.J., Marino M.W., and Winckler W.M. Altered pathological progression of diaphragm and quadriceps muscle in TNF-deficient, dystrophin-deficient mice. Neuromuscul. Disord. 10 (2000) 612-619
22. Spencer M.J., Walsh C.M., Dorshkind K.A., Rodriguez E.M., and Tidball J.G. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Invest. 99 (1997) 2745-2751
23. Johnstone R.W., Cretney E., and Smyth M.J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93 (1999) 1075-1085
24. Zhou S., Zong Y., Lu T., and Sorrentino B.P. Hematopoietic cells from mice that are deficient in both Bcrp1/Abcg2 and Mdr1a/1b develop normally but are sensitized to mitoxantrone. BioTechniques 35 (2003) 1248-1252
25. Pinheiro C., and Bates D.M. Mixed-Effects Models in S and S-PLUS (2000), Springer
26. Hamer P.W., McGeachie J.M., Davies M.J., and Grounds M.D. Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J. Anat. 200 (2002) 69-79
27. Lu Q.L., Rabinowitz A., Chen Y.C., Yokota T., Yin H., Alter J., Jadoon A., Bou-Gharios G., and Partridge T. Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 198-203 (Electronic publication 2004 Dec 17)
28. Anderson J.E. Dystrophic changes in mdx muscle regenerating from denervation and devascularization. Muscle Nerve 14 (1991) 268-279
29. Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A., and Oren M. A novel p53-inducible gene, PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J. 16 (1997) 4384-4392
30. Benchaouir R., Rameau P., Decraene C., Dreyfus P., Israeli D., Pietu G., Danos O., and Garcia L. Evidence for a resident subset of cells with SP phenotype in the C2C12 myogenic line: a tool to explore muscle stem cell biology. Exp. Cell Res. 294 (2004) 254-268
31. Fukada S., Higuchi S., Segawa M., Koda K., Yamamoto Y., Tsujikawa K., Kohama Y., Uezumi A., Imamura M., Miyagoe-Suzuki Y., Takeda S., and Yamamoto H. Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody. Exp. Cell Res. 296 (2004) 245-255
32. DiMario J.X., Uzman A., and Strohman R.C. Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle. Dev. Biol. 148 (1991) 314-321
33. Yokota T., Lu Q.L., Morgan J.E., Davies K.E., Fisher R., Takeda S., and Partridge T.A. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J. Cell Sci. 119 (2006) 2679-2687 (Electronic publication 2006 Jun 6.)
34. Goodell M.A., Brose K., Paradis G., Conner A.S., and Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 (1996) 1797-1806
35. Gussoni E., Soneoka Y., Strickland C.D., Buzney E.A., Khan M.K., Flint A.F., Kunkel L.M., and Mulligan R.C. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401 (1999) 390-394
36. Bunting K.D., Zhou S., Lu T., and Sorrentino B.P. Enforced P-glycoprotein pump function in murine bone marrow cells results in expansion of side population stem cells in vitro and repopulating cells in vivo. Blood 96 (2000) 902-909
37. Jonker J.W., Freeman J., Bolscher E., Musters S., Alvi A.J., Titley I., Schinkel A.H., and Dale T.C. Contribution of the ABC-transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells 25 (2005) 1059-1065
38. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., and Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7 (2001) 1028-1034
39. Cisternino S., Mercier C., Bourasset F., Roux F., and Scherrmann J.M. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier. Cancer Res. 64 (2004) 3296-3301
40. Meeson A.P., Hawke T.J., Graham S., Jiang N., Elterman J., Hutcheson K., Dimaio J.M., Gallardo T.D., and Garry D.J. Cellular and molecular regulation of skeletal muscle side population cells. Stem Cells 22 (2004) 1305-1320
41. Kaufman S.J., and Foster R.F. Replicating myoblasts express a muscle-specific phenotype. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 9606-9610
42. Smythe G.M., Davies M.J., Paulin D., and Grounds M.D. Absence of desmin slightly prolongs myoblast proliferation and delays fusion in vivo in regenerating grafts of skeletal muscle. Cell. Tissue Res. 304 (2001) 287-294
43. Beauchamp J.R., Morgan J.E., Pagel C.N., and Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144 (1999) 1113-1122
44. Heslop L., Morgan J.E., and Partridge T.A. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J. Cell Sci. 113 (2000) 2299-2308
45. Barton E.R., Morris L., Musaro A., Rosenthal N., and Sweeney H.L. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J. Cell Biol. 157 (2002) 137-148 (Electronic publication 2002 Apr 1)
46. Bogdanovich S., Krag T.O., Barton E.R., Morris L.D., Whittemore L.A., Ahima R.S., and Khurana T.S. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420 (2002) 418-421
47. Uezumi A., Ojima K., Fukada S., Ikemoto M., Masuda S., Miyagoe-Suzuki Y., and Takeda S. Functional heterogeneity of side population cells in skeletal muscle. Biochem. Biophys. Res. Commun. 341 (2006) 864-873 (Electronic publication 2006 Jan 23)
48. Tadjali M., Zhou S., Rehg J., and Sorrentino B.P. Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele. Stem Cells 16 (2006) 16
49. Asakura A., and Rudnicki M.A. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol. 30 (2002) 1339-1345
50. Cossu G., and Biressi S. Satellite cells, myoblasts and other occasional myogenic progenitors: possible origin, phenotypic features and role in muscle regeneration. Semin. Cell Dev. Biol. 16 (2005) 623-631
51. Nagata Y., Partridge T.A., Matsuda R., and Zammit P.S. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol. 174 (2006) 245-253
52. van Helvoort A., Smith A.J., Sprong H., Fritzsche I., Schinkel A.H., Borst P., and van Meer G. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87 (1996) 507-517
53. Bachrach E., Perez A.L., Choi Y.H., Illigens B.M., Jun S.J., del Nido P., McGowan F.X., Li S., Flint A., Chamberlain J., and Kunkel L.M. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve 34 (2006) 44-52
54. Hirschmann-Jax C., Foster A.E., Wulf G.G., Goodell M.A., and Brenner M.K. A distinct "side population" of cells in human tumor cells: implications for tumor biology and therapy. Cell Cycle 4 (2005) 2
55. Israeli D., Ziaei S., Gonin P., and Garcia L. A proposal for the physiological significance of mdr1 and Bcrp1/Abcg2 gene expression in normal tissue regeneration and after cancer therapy. J. Theor. Biol. 232 (2005) 41-45